Magnetic resonance venography to assess thrombus resolution with edoxaban monotherapy versus parenteral anticoagulation/warfarin for symptomatic deep vein thrombosis: A multicenter feasibility study

In conclusion, MRV can assess change in thrombus volume in patients with acute DVT randomized to two different anticoagulant regimens.
ClinicalTrials.gov Identifier: NCT01662908
Investigational New Drug (IND) Application: Edoxaban IND # 63266

Source: Vascular Medicine - July 24, 2016 Category: Internal Medicine Authors: Piazza, G., Mani, V., Goldhaber, S. Z., Grosso, M. A., Mercuri, M., Lanz, H. J., Schussler, S., Hsu, C., Chinigo, A., Ritchie, B., Nadar, V., Cannon, K., Pullman, J., Concha, M., Schul, M., Fayad, Z. A., for the edoxaban Thrombus Reduction Imaging Study ( Tags: Original Articles Source Type: research